The potential osteogenic effects of systemic leptin and insulin administration in streptozotocin-induced diabetic female rats - PubMed (original) (raw)
. 2007 Aug;28(8):1185-90.
Affiliations
- PMID: 17676199
The potential osteogenic effects of systemic leptin and insulin administration in streptozotocin-induced diabetic female rats
Hayam I Gad. Saudi Med J. 2007 Aug.
Abstract
Objective: To evaluate the effect of leptin administration on some biochemical parameters of bone turnover in diabetic rats using either leptin alone or a combination of leptin and insulin.
Methods: The study was carried out on 32 female Wistar rats supplied by the Medical College animal house at King Khalid Hospital, Riyadh, Kingdom of Saudi Arabia during the period from March to December 2006. Rats were divided into 4 groups (8 rats each), controls, non-treated diabetic, leptin-treated diabetic, and leptin plus insulin-treated diabetic rats. After induction of diabetes by 6 weeks, treatment with leptin either alone or combined with insulin was continued for 2 weeks more. At the end of treatment, serum samples were taken to measure levels of bone alkaline phosphatase (BAP), alkaline phosphatase, osteocalcin, insulin like growth factor-1 (IGF-1), parathyroid hormone (PTH), glucose, creatinine, calcium ions (Ca2+), and phosphorus using enzyme-linked immunoassay (ELISA) and spectrophotometric methods. Body weight and urinary calcium excretion were also measured.
Results: Combined leptin and insulin treatment produced a significant increase of serum BAP and a decrease of urinary calcium and serum glucose as compared to rats treated by leptin only, and a significant increase of BAP, alkaline phosphates, IGF-1, and glucose and a decrease in osteocalcin as compared to control rats. Positive correlations were detected between serum IGF-1 levels and each of BAP, alkaline phosphatase, and osteocalcin in diabetic rats treated by leptin, and those with leptin plus insulin.
Conclusion: Combined leptin plus insulin treatment can offer extra gain of bone formation over leptin treatment alone. Confirmation of these preliminary observations must await careful long-term studies of bone turnover in experimental diabetes.
Similar articles
- The relationship between nitric oxide and leptin in the lung of rat with streptozotocin-induced diabetes.
Oztay F, Kandil A, Gurel E, Ustunova S, Kapucu A, Balci H, Akgun-Dar K, Demirci C. Oztay F, et al. Cell Biochem Funct. 2008 Mar-Apr;26(2):162-71. doi: 10.1002/cbf.1418. Cell Biochem Funct. 2008. PMID: 17542037 - Effects of insulin and sulphonylureas on insulin-like growth factor-I levels in streptozotocin-induced diabetic rats.
Guney E, Kisakol G, Oge A, Yilmaz C, Kabalak T. Guney E, et al. Neuro Endocrinol Lett. 2002 Oct-Dec;23(5-6):437-9. Neuro Endocrinol Lett. 2002. PMID: 12500166 - Effects of a Combination Therapy of Sclerostin Antibody III and Raloxifene on Bone Formation Markers in Ovariectomized Rats.
Gad Allam HI. Gad Allam HI. J Coll Physicians Surg Pak. 2016 Jan;26(1):46-50. J Coll Physicians Surg Pak. 2016. PMID: 26787031 - The complex effects of leptin on bone metabolism through multiple pathways.
Thomas T. Thomas T. Curr Opin Pharmacol. 2004 Jun;4(3):295-300. doi: 10.1016/j.coph.2004.01.009. Curr Opin Pharmacol. 2004. PMID: 15140423 Review.
Cited by
- Leptin treatment prevents type I diabetic marrow adiposity but not bone loss in mice.
Motyl KJ, McCabe LR. Motyl KJ, et al. J Cell Physiol. 2009 Feb;218(2):376-84. doi: 10.1002/jcp.21608. J Cell Physiol. 2009. PMID: 18932203 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Miscellaneous